Shares of ImmuPharma plc (LON:IMM – Get Free Report) traded down 3.7% during mid-day trading on Tuesday . The company traded as low as GBX 1.01 ($0.01) and last traded at GBX 1.13 ($0.01). 101,468 shares traded hands during mid-day trading, a decline of 94% from the average session volume of 1,784,371 shares. The stock had previously closed at GBX 1.17 ($0.01).
ImmuPharma Stock Down 14.0 %
The stock has a market cap of £4.19 million, a PE ratio of -116.75 and a beta of 1.53. The firm’s fifty day moving average price is GBX 1.65 and its 200 day moving average price is GBX 1.80.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
Featured Stories
- Five stocks we like better than ImmuPharma
- How to Use Stock Screeners to Find Stocks
- How to Master Trading Discipline: Overcome Emotional Challenges
- What is Put Option Volume?
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- Best Stocks Under $10.00
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
